Ghazaleh Tabatabai
@ghtabatabai.bsky.social
150 followers
100 following
14 posts
Neurologist.Physician Scientist. Neurooncologist. Molecular Biology.
Early PhaseClinical Trials.
Full Professor&Managing Director.
Passionate about Music&Literature.
@unituebingen.bsky.social
@neurooncotue.bsky.social
Posts
Media
Videos
Starter Packs
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Martin Jungkunz
@martin-jk.bsky.social
· May 30
Reposted by Ghazaleh Tabatabai
Martin Jungkunz
@martin-jk.bsky.social
· May 30
Reposted by Ghazaleh Tabatabai
Martin Jungkunz
@martin-jk.bsky.social
· May 30
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
EANO
@eanoassociation.bsky.social
· May 30
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
AbstractBackground. Meningiomas are the most common primary intracranial neoplasms, with highly variable patient outcomes. While most meningiomas are benig
doi.org
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
EANO
@eanoassociation.bsky.social
· Apr 18
Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH‐mutant and 1p/19q codeleted: A French POLA netwo...
Young patients under 40 years of age with grade 3 oligodendroglioma show distinct molecular profiles, including fewer CDKN2A deletions and specific chromosomal abnormalities, compared to those over 4....
acsjournals.onlinelibrary.wiley.com
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai
Reposted by Ghazaleh Tabatabai